ArticleObesity surgery2026
Risk-Stratified Thromboembolic and Bleeding Outcomes Following Sleeve Gastrectomy Under Uniform Extended Enoxaparin Prophylaxis.
Article in Obesity surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
objectiveVenous thromboembolism (VTE) remains a relevant complication after bariatric surgery despite routine extended thromboprophylaxis. This study evaluated 90-day thromboembolic and bleeding outcomes following laparoscopic sleeve gastrectomy under a standardized enoxaparin protocol and examined their association with baseline risk assessed by the Caprini Risk Assessment Model.
methodsThis retrospective cohort study included 348 patients who underwent primary laparoscopic sleeve gastrectomy between 2015 and 2025. All patients received extended enoxaparin prophylaxis for 21 days. Patients were stratified into low (≤ 4), moderate (5-6), and high (≥ 7) risk groups according to Caprini score. The primary outcome was 90-day VTE. Secondary outcomes included bleeding events and hospital readmission. Comparative analyses, univariable logistic regression, and receiver operating characteristic (ROC) analyses were performed.
resultsThe incidence of VTE increased progressively across risk categories (0.9%, 3.2%, and 8.9% in the low-, moderate-, and high-risk groups, respectively; p = 0.006). Clinically relevant minor bleeding also increased across groups (4.9%, 8.3%, and 12.2%, respectively; p = 0.047), whereas major bleeding remained infrequent (2.0%, 2.6%, and 4.4%; p = 0.284). In univariable analysis, the Caprini score was significantly associated with 90-day VTE (OR: 1.48, 95% CI: 1.26-1.74; p < 0.001). ROC analysis demonstrated acceptable discriminative performance (AUC: 0.78, 95% CI: 0.70-0.86), with an optimal cut-off value of ≥ 7 (sensitivity: 78.6%, specificity: 71.2%, negative predictive value: 96.8%).
conclusionWithin a homogeneous cohort undergoing laparoscopic sleeve gastrectomy and managed with standardized extended enoxaparin prophylaxis, thromboembolic and bleeding outcomes varied according to baseline VTE risk. Thromboembolic events increased progressively across Caprini risk categories despite uniform prophylaxis, whereas major bleeding remained uncommon. These findings support further evaluation of risk-adapted thromboprophylaxis strategies. Given the retrospective design and limited number of thromboembolic events, the results should be considered hypothesis-generating and require confirmation in prospective studies.
Indexed as
Identifiers
42631907What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.